Tranxamic acid in cervical ectropion

Comparison of the therapeutic effect of tranexamic acid with cryotherapy in the treatment of symptoms of cervical ectropion in patients referred to the gynecology clinic of Ayatollah Mousavi Hospital in Zanjan during 2022 and 2023: a randomized clinical trial study

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20220115053719N1

Enrollment

Registered

2022-02-07

Start date

2022-03-20

Completion date

Unknown

Last updated

2022-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical ectropion. Erosion and ectropion of cervix uteri

Interventions

Intervention 1: Intervention group: 500 mg Tranexamic Acid vaginal tablet daily for 10 days. Intervention 2: Control group: cryotherapy, The cryotherapy probe will be selected based on the size and lo

Eligibility

Sex/Gender

Female

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Patients who have been diagnosed with cervical ectropion by an experienced gynecologist.

Exclusion criteria

Exclusion criteria: Pregnancy Having any known malignancy Patients in the Menopause period Intrauterine device (IUD) Taking contraceptives in the recent 3 months

Design outcomes

Primary

Measure	Time frame
Pelvic pain. Timepoint: Patients' pain will be evaluated at intervals of zero, the seventh day, the fourteenth day, the twenty-first day, the twenty-eighth day, the sixtieth day and the ninetieth day. Method of measurement: Visual Analogue Scale will be used to determine the pain.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFarzane Hekmatfar

Zanjan University of Medical Sciences

Hekmatfar.farzaneh@zums.ac.ir+98 915 119 6198

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 6, 2026